Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousGraft vs Host DiseaseTransplantation ConditioningBone MarrowBone Marrow CellsHematopoietic Stem Cell MobilizationTissue DonorsGraft SurvivalHematopoietic Stem CellsTransplantation ChimeraGranulocyte Colony-Stimulating FactorHematologic NeoplasmsLeukapheresisImmunosuppressive AgentsTreatment OutcomeStem CellsHistocompatibility TestingHistocompatibilityAntigens, CD34Blood Component RemovalStem Cell TransplantationWhole-Body IrradiationLeukemiaAnemia, AplasticCombined Modality TherapyCyclophosphamideMelphalanRecurrenceBusulfanCytomegalovirus InfectionsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsTime FactorsBone Marrow PurgingHematopoiesisBone and BonesRetrospective StudiesGraft RejectionBlood CellsImmunosuppressionBone Marrow DiseasesLymphoma, Non-HodgkinSurvival AnalysisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation, IsogeneicOpportunistic InfectionsLeukocyte TransfusionCord Blood Stem Cell TransplantationImmunocompromised HostLymphocyte DepletionHLA AntigensBlood DonorsPrecursor Cell Lymphoblastic Leukemia-LymphomaDisease-Free SurvivalLeukemia, Myeloid, AcuteRemission InductionBlood Cell CountT-LymphocytesKidney TransplantationMyeloablative AgonistsAcute DiseaseSurvival RateMice, Inbred C57BLHematologic DiseasesFlow CytometryCyclosporineEtoposideInfectionRadiation ChimeraTransplantationColony-Forming Units AssayThiotepaFatal OutcomeCytomegalovirusGraft Enhancement, ImmunologicTransplantation ToleranceChimerismAntineoplastic Agents, AlkylatingHodgkin DiseaseCell DifferentiationTransplantation ImmunologyNeoplasmsSalvage TherapyFollow-Up StudiesCell SeparationMyelodysplastic SyndromesCells, CulturedLeukocyte CountMycosesProspective StudiesPolymerase Chain ReactionImmunophenotypingLymphomaPlatelet CountGanciclovirBone Marrow Examination